TABLE 2.
Clinical Features of Patients With Postoperative Toxic Keratitis
Case | Sex/Age (yrs) | Underlying Disease |
History of HSK | Type of Surgery | Cornea Before Cataract Operation |
Time Between Surgery and Presentation (d) |
||||
---|---|---|---|---|---|---|---|---|---|---|
1 | Female/66 | None | No history | Phaco + PCL | Clear | 5 | ||||
2 | Female/71 | None | No history | Phaco + PCL | Clear | 5 | ||||
3 | Female/55 | None | No history | Phaco + PCL + PPV | Clear | 7 | ||||
4 | Female/61 | DM | No history | Phaco + PCL + PPV | Clear | 2 | ||||
Case |
Perioperative Medication |
Initial Diagnosis |
Initial Clinical Manifestation |
Incision Location |
Final Diagnosis |
Medication After Diagnosis |
HSV-1 PCR |
|||
1 | Topical steroids and antibiotics | Toxic keratitis | Diffuse SPEs | Superior | Toxic keratitis | Lubrication | Negative | |||
2 | Topical steroids and antibiotics | Toxic keratitis | Diffuse SPEs | Temporal | Toxic keratitis | Lubrication | Negative | |||
3 | Topical steroids and antibiotics | Toxic keratitis | Diffuse SPEs | Temporal | Toxic keratitis | Lubrication | Negative | |||
4 | Topical steroids and antibiotics | Toxic keratitis | Diffuse SPEs | Superior | Toxic keratitis | Lubrication | Negative |
PE, superficial punctate erosion; Phaco + PCL, phacoemulsification and posterior chamber lens insertion; Phaco +PCL + PPV, phacoemulsification and posterior chamber lens insertion and pars plana vitrectomy.